[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100633473":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":22,"centralContacts":27,"locations":36,"responsibleParty":53,"collaborators":10,"id":56,"slug":10,"hasResults":57,"nctId":58,"briefTitle":59,"officialTitle":59,"acronym":10,"eligibilityCriteria":60,"healthyVolunteers":61,"sex":62,"minAge":63,"maxAge":10,"enrollmentInfo":64,"targetDuration":10,"studyType":67,"phases":10,"briefSummary":68,"conditions":69,"keywords":10,"overallStatus":71,"whyStopped":10,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":81},{"fullName":5,"class":6},"Mayo Clinic","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Observational",null,"Participants complete a semi-structured interview on study.",[13],"Other: Non-Interventional Study",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":19},"Non-Interventional Study","Non-interventional study",[9],[20,21],"Non-Interventional Observational Study","Noninterventional (Observational) Study",[23],{"name":24,"affiliation":25,"role":26},"Shariska Harrington, MD","Mayo Clinic in Rochester","PRINCIPAL_INVESTIGATOR",[28,33],{"name":29,"role":30,"phone":31,"phoneExt":10,"email":32},"Clinical Trials Referral Office","CONTACT","855-776-0015","mayocliniccancerstudies@mayo.edu",{"name":34,"role":30,"phone":35,"phoneExt":10,"email":10},"Kelly Gunderson","507-422-1892",[37],{"facility":25,"status":10,"city":38,"state":39,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"Rochester","Minnesota","55905","United States","US",{"type":44,"coordinates":45},"Point",[46,47],-92.4699,44.02163,{"lat":47,"lon":46},[50,51,52],{"name":29,"role":30,"phone":31,"phoneExt":10,"email":10},{"name":34,"role":30,"phone":35,"phoneExt":10,"email":10},{"name":24,"role":26,"phone":10,"phoneExt":10,"email":10},{"type":26,"investigatorFullName":54,"investigatorTitle":55,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Shariska Harrington","Principal Investigator","100633473",false,"NCT07527143","Acceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial Cancer","Inclusion Criteria:\n\n* Self-identified Black individuals ≥ 45 years with an intact uterus\n* Assigned female sex at birth\n* Willing to participate in a 30-minute virtual interview\n\nExclusion Criteria:\n\n* Previous or current diagnosis of endometrial cancer",true,"FEMALE","45 Years",{"count":65,"type":66},25,"ESTIMATED","OBSERVATIONAL","This study evaluates how women feel about using DNA from a vaginal fluid collection for early detection of endometrial cancer.",[70],"Endometrial Carcinoma","NOT_YET_RECRUITING","2026-04-07",{"date":74,"type":75},"2026-04-14","ACTUAL",{"date":77,"type":66},"2026-04-06",{"date":79,"type":66},"2027-04-06",{"name":5,"class":6},1]